CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Wu Xiaobin President and COO | Sale | −10 | $382.32 | $4K | 0 |
| 2025-11-13 | Wu Xiaobin President and COO | Sale | −4,240 | $380.33 | $1.6M | 1,769 |
| 2025-11-13 | Wu Xiaobin President and COO | Sale | −1,769 | $381.05 | $674K | 0 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +302 | $194.47 | $59K | 302 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +398 | $213.32 | $85K | 700 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise 10b5-1 | +296 | $159.03 | $47K | 996 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −664 | $348.75 | $232K | 332 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Sale 10b5-1 | −332 | $350.00 | $116K | 0 |
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −3,926 | 35,698 | ||
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −5,174 | 103,935 | ||
| 2025-11-12 | Lee Chan Henry SVP, General Counsel | Option exercise · Share Option (Right to Buy) 10b5-1 | −3,848 | 123,214 | ||
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −500 | $350.44 | $175K | 15,509 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −3,240 | $351.41 | $1.1M | 12,269 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −789 | $352.78 | $278K | 11,480 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −251 | $354.20 | $89K | 11,229 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −120 | $355.00 | $43K | 11,109 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −100 | $357.43 | $36K | 11,009 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −4,846 | $360.10 | $1.7M | 6,163 |
| 2025-11-12 | Wu Xiaobin President and COO | Sale | −154 | $362.07 | $56K | 6,009 |
| 2025-11-12 | OYLER JOHN Chief Executive Officer | Gift | −858,533 | 6,441,041 |
Page 18 of 71 · 1,406 trades